Your browser doesn't support javascript.
loading
Immunogenicity and safety of the 9-valent HPV vaccine in men.
Castellsagué, X; Giuliano, A R; Goldstone, S; Guevara, A; Mogensen, O; Palefsky, J M; Group, T; Shields, C; Liu, K; Maansson, R; Luxembourg, A; Kaplan, S S.
Afiliação
  • Castellsagué X; Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, CIBERESP, L'Hospitalet de Llobregat, Catalonia, Spain. Electronic address: xcastellsague@iconcologia.net.
  • Giuliano AR; Center for Infection Research in Cancer (CIRC) at Moffitt Cancer Center, Tampa, FL, USA.
  • Goldstone S; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Guevara A; Research Unit, Pablo Tobon Uribe Hospital Medellin, Medellín, Colombia.
  • Mogensen O; Department of Gynaecology and Obstetrics, Odense University Hospital, Odense, Denmark.
  • Palefsky JM; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Group T; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Shields C; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Liu K; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Maansson R; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Luxembourg A; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Kaplan SS; Merck & Co., Inc., Kenilworth, NJ, USA.
Vaccine ; 33(48): 6892-901, 2015 Nov 27.
Article em En | MEDLINE | ID: mdl-26144901

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Vacinas contra Papillomavirus Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Vacinas contra Papillomavirus Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article